Tag: iShares NASDAQ Biotechnology ETF

S&P in Orderly High Level Consolidation Phase

recent trading actions leaving the S&P in what looks to us like an orderly high level consolidation of the March rally. The index is ticking ever closer to 2900, a level it has not breached since market broke down in late 2018. Some aggressive traders might use this level like a magnet to sell against, but it doesn’t have much significance outside of just being a nice round number

Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech stocks.  The group attracted strong buying support in recent day that saw the iShares Nasdaq Biotechnology ETF (IBB) surged more than 4 percent last week, bringing its YTD gains up to 14.4 percent while the S&P gained 8.5 percent […]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  Biotech caught a bid Friday after Biogen announced positive results from a study on a drug aimed at treating early Alzheimer’s disease, its shares rose nearly 20 percent.  The iShares Nasdaq Biotechnology ETF (IBB) surged 3.8 percent, bringing its YTD gains up to nearly 9 percent, outperformed the S&P by a wide margin.  Now […]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech.  The iShares Nasdaq Biotechnology ETF (IBB) now up about 12% from its November lows to trade at 112, near two-year nigh.  Not only is that IBB overbought following recent advance, the ETF also drawing the attention of bears.  Now […]

Next Page »